-
Survivor Profile
A Recovery MindsetResearcher and esophageal cancer survivor Laurie Betts leans into past lessons learned, including the value of service to others, to get through cancer.
by Lindsey Konkel Neabore
-
Chemo or Not?
Tumor profiling tests that predict the likelihood of distant recurrence can help some women with early-stage, hormone receptor-positive breast cancer decide on treatments after surgery.
by Kris Conner
-
Forward Look
Targeting Cancer in KidsNew studies probe how to match targeted therapies to children with cancer.
by Stephen Ornes
-
Forward Look
What’s NextA magnet-guided robot could help doctors look for signs of cancer deeper in the passages of the lungs.
by Darcy Lewis
-
Taking Stock of CAR T-Cell Therapy
Five years after the FDA approved the first CAR T-cell therapy, use of the treatment has expanded to many patients with blood cancer.
by Kendall K. Morgan
-
The View From a CAR T-Cell Clinical Trial
After exhausting her treatment options, Ellen Reich got CAR T-cell treatment for multiple myeloma through a clinical trial.
by Pamela Rafalow Grossman
-
Forward Look
Drug Combinations for Advanced MelanomaResearchers find that when treating metastatic melanoma, timing is everything.
by Erin O'Donnell
-
Q&A
Show Me You CareTheresa Brown, who was a nurse when she was diagnosed with breast cancer, writes about deep gaps in her own care.
by Marci A. Landsmann
-
Healthy Habits
Signs of Skin CancerRegularly checking your skin is crucial to catching skin cancer early.
by Tara Santoro
-
Comorbidity: Treating the Whole Patient
Patients with cancer often have at least one other chronic disease. Researchers hope to shine a light on how conditions and treatments interact in patients with chronic lymphocytic leukemia and other cancer types.
by Eric Fitzsimmons
Cancer Talk
Immunotherapy Improves Survival in Bladder Cancer
New research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff